202 related articles for article (PubMed ID: 33221266)
1. 60 Years after Kefauver: Household income required to buy prescription drugs in the United States and abroad.
Mattingly TJ; Seo D; Ostrovsky AM; Vanness DJ; Conti RM
Res Social Adm Pharm; 2021 Aug; 17(8):1489-1495. PubMed ID: 33221266
[TBL] [Abstract][Full Text] [Related]
2. High prices for generics in Australia - more competition might help.
Bulfone L
Aust Health Rev; 2009 May; 33(2):200-14. PubMed ID: 19563309
[TBL] [Abstract][Full Text] [Related]
3. The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.
Kesselheim AS; Avorn J; Sarpatwari A
JAMA; 2016 Aug 23-30; 316(8):858-71. PubMed ID: 27552619
[TBL] [Abstract][Full Text] [Related]
4. Why France Spends Less Than the United States on Drugs: A Comparative Study of Drug Pricing and Pricing Regulation.
Raimond VC; Feldman WB; Rome BN; Kesselheim AS
Milbank Q; 2021 Mar; 99(1):240-272. PubMed ID: 33751664
[TBL] [Abstract][Full Text] [Related]
5. International Reference Pricing for Prescription Drugs in the United States: Administrative Limitations and Collateral Effects.
Rand LZ; Kesselheim AS
Value Health; 2021 Apr; 24(4):473-476. PubMed ID: 33840424
[TBL] [Abstract][Full Text] [Related]
6. Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis.
Iyengar S; Tay-Teo K; Vogler S; Beyer P; Wiktor S; de Joncheere K; Hill S
PLoS Med; 2016 May; 13(5):e1002032. PubMed ID: 27243629
[TBL] [Abstract][Full Text] [Related]
7. Tiered co-payments, pricing, and demand in reference price markets for pharmaceuticals.
Herr A; Suppliet M
J Health Econ; 2017 Dec; 56():19-29. PubMed ID: 28964941
[TBL] [Abstract][Full Text] [Related]
8. Trends in Prices of Drugs Used to Treat Metastatic Non-Small Cell Lung Cancer in the US From 2015 to 2020.
Desai A; Scheckel C; Jensen CJ; Orme J; Williams C; Shah N; Leventakos K; Adjei AA
JAMA Netw Open; 2022 Jan; 5(1):e2144923. PubMed ID: 35076701
[TBL] [Abstract][Full Text] [Related]
9. Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability.
Husain MJ; Datta BK; Kostova D; Joseph KT; Asma S; Richter P; Jaffe MG; Kishore SP
J Am Heart Assoc; 2020 May; 9(9):e015302. PubMed ID: 32338557
[TBL] [Abstract][Full Text] [Related]
10. Access and Affordability of Medicines in Malaysia: Need for a National Pricing Policy.
Wong SL; Ibrahim S; Abdul Kadir N; Mohd Salleh S
Appl Health Econ Health Policy; 2019 Oct; 17(5):641-654. PubMed ID: 31093937
[TBL] [Abstract][Full Text] [Related]
11. Trends in Prices of Popular Brand-Name Prescription Drugs in the United States.
Wineinger NE; Zhang Y; Topol EJ
JAMA Netw Open; 2019 May; 2(5):e194791. PubMed ID: 31150077
[TBL] [Abstract][Full Text] [Related]
12. The Price to Consumers of Generic Pharmaceuticals: Beyond the Headlines.
Frank RG; Hicks A; Berndt ER
Med Care Res Rev; 2021 Oct; 78(5):585-590. PubMed ID: 32468959
[TBL] [Abstract][Full Text] [Related]
13. Estimates of Medicaid and Non-Medicaid Net Prices of Top-Selling Brand-name Drugs Incorporating Best Price Rebates, 2015 to 2019.
Clemans-Cope L; Epstein M; Banthin J; Kesselheim AS; Hwang TJ
JAMA Health Forum; 2023 Jan; 4(1):e225012. PubMed ID: 36637815
[TBL] [Abstract][Full Text] [Related]
14. International drug price comparisons: quality assessment.
Machado M; O'Brodovich R; Krahn M; Einarson TR
Rev Panam Salud Publica; 2011 Jan; 29(1):46-51. PubMed ID: 21390419
[TBL] [Abstract][Full Text] [Related]
15. Generic Drugs in the United States: Policies to Address Pricing and Competition.
Gupta R; Shah ND; Ross JS
Clin Pharmacol Ther; 2019 Feb; 105(2):329-337. PubMed ID: 30471089
[TBL] [Abstract][Full Text] [Related]
16. Using External Reference Pricing In Medicare Part D To Reduce Drug Price Differentials With Other Countries.
Kang SY; DiStefano MJ; Socal MP; Anderson GF
Health Aff (Millwood); 2019 May; 38(5):804-811. PubMed ID: 31059372
[TBL] [Abstract][Full Text] [Related]
17. Points to consider about prescription drug prices: an overview of federal policy and pricing studies.
Kucukarslan S; Hakim Z; Sullivan D; Taylor S; Grauer D; Haugtvedt C; Zgarrick D
Clin Ther; 1993; 15(4):726-38. PubMed ID: 8221823
[TBL] [Abstract][Full Text] [Related]
18. Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending.
Wouters OJ; Kanavos PG; McKEE M
Milbank Q; 2017 Sep; 95(3):554-601. PubMed ID: 28895227
[TBL] [Abstract][Full Text] [Related]
19. The Impact of a Pricing Policy Change on Retail Prices of Medicines in Egypt.
Mohamed O; Kreling DH
Value Health Reg Issues; 2016 Sep; 10():14-18. PubMed ID: 27881272
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical pricing in emerging markets: effects of income, competition, and procurement.
Danzon PM; Mulcahy AW; Towse AK
Health Econ; 2015 Feb; 24(2):238-52. PubMed ID: 24293058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]